A Prospective Trial of 68Ga-PSMA and 18F-FDG PET/CT in Nonmetastatic Prostate Cancer Patients with an Early PSA Progression During Castration.

Beihe WangChang LiuYu WeiJin MengYingjian ZhangHualei GanXiaoping XuFangning WanJian PanXuejun MaSilong HuStephen J FreedlandShaoli SongDingWei YeYao Zhu

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

Using 68Ga-PSMA and 18F-FDG PET, we observed a high prevalence of N+/M+ disease and a significant proportion of PSMA-FDG+ disease in patients with an early PSA progression during castration (ChiCTR1900022634).

Keyphrases

pet ct
prostate cancer
radical prostatectomy
positron emission tomography
pet imaging
clinical trial
study protocol
randomized controlled trial
phase ii
double blind